FDA
-
-
-
-
-
-
-
IVERIC bio (ISEE) Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER Trials
-
-
-
-
-
-
-
Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors
-
-
-
-
-
-
-
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
-
-
-
-
-
-
-
DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura®
-
-
-
-
-
-
-
Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
-
-
-
-
-
-
-
Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule
-
-
-
-
-
-
-
Iveric Bio Reports Fourth Quarter and Year End 2020 Operational Highlights and Financial Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

